Vaccine development in Staphylococcus aureus: taking the biofilm phenotype into consideration
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Vaccine development against pathogenic bacteria is an imperative initiative as bacteria are gaining resistance to current antimicrobial therapies and few novel antibiotics are being developed. Candidate antigens for vaccine development can be identified by a multitude of high-throughput technologies that were accelerated by access to complete genomes. While considerable success has been achieved in vaccine development against bacterial pathogens, many species with multiple virulence factors and modes of infection have provided reasonable challenges in identifying protective antigens. In particular, vaccine candidates should be evaluated in the context of the complex disease properties, whether planktonic (e.g. sepsis and pneumonia) and/or biofilm associated (e.g. indwelling medical device infections). Because of the phenotypic differences between these modes of growth, those vaccine candidates chosen only for their efficacy in one disease state may fail against other infections. This review will summarize the history and types of bacterial vaccines and adjuvants as well as present an overview of modern antigen discovery and complications brought about by polymicrobial infections. Finally, we will also use one of the better studied microbial species that uses differential, multifactorial protein profiles to mediate an array of diseases, Staphylococcus aureus, to outline some of the more recently identified problematic issues in vaccine development in this biofilm-forming species.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Pseudomonas aeruginosa quorum‐sensing molecule influences Candida albicans morphology
Hogan, D. A., Vik, Å., & Kolter, R. (2004) · Molecular Microbiology · doi:10.1111/j.1365-2958.2004.04349.x · Cited by 575
Vaccine assembly from surface proteins of Staphylococcus aureus
Stranger-Jones, Y. K., Bae, T., & Schneewind, O. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0606863103 · Cited by 309
Kaplan, J. B., Velliyagounder, K., Ragunath, C., Rohde, H., Mack, D., Knobloch, J. K.-M., & Ramasubbu, N. (2004) · Journal of Bacteriology · doi:10.1128/jb.186.24.8213-8220.2004 · Cited by 301 · cited 2×
“This work was funded by the National Institute of Allergy and Infectious Diseases, National Institutes of Health grant R01 AI69568-01A2.”
BackgroundMethodBamford, C. V., d'Mello, A., Nobbs, A. H., Dutton, L. C., Vickerman, M. M., & Jenkinson, H. F. (2009) · Infection and Immunity · doi:10.1128/iai.00438-09 · Cited by 291 · cited 1×
“These altered microbial and host profiles are likely due to the unique physical interactions and chemical signaling events that occur during the development of polymicrobial communities (Hogan et al., 2004; Bamford et al., 2009).”
BackgroundHost defense and pathogenesis in Staphylococcus aureus infections
DeLeo, F. R., Diep, B. A., & Otto, M. (2009) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2008.10.003 · Cited by 269 · cited 1×
“This microbial species has dozens of known toxins, multiple immunoavoidance, and adherence factors, most of which demonstrate transient, timed, and disease-specific expression (DeLeo et al., 2009).”
BackgroundIdentification of in vivo expressed vaccine candidate antigens from Staphylococcus aureus
Etz, H., Minh, D. B., Henics, T., Dryla, A., Winkler, B., Triska, C., Boyd, A. P., Söllner, J., Schmidt, W., von Ahsen, U., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.092569199 · Cited by 218 · cited 2×
“The screens identify a large repertoire of antigenic peptides including those encoded by alternate reading frames (Etz et al., 2002).”
BackgroundAnchorless adhesins and invasins of Gram-positive bacteria: a new class of virulence factors
Chhatwal, G. S. (2002) · Trends in Microbiology · doi:10.1016/s0966-842x(02)02351-x · Cited by 167
Kim, H. K., DeDent, A., Cheng, A. G., McAdow, M., Bagnoli, F., Missiakas, D. M., & Schneewind, O. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.02.097 · Cited by 158 · cited 2×
“…tended to focus on testing the ability of target antigens to protect the host from in vitro or murine planktonic infection models (Fattom et al., 1996, 2004; McKenney et al., 1998, 1999, 2000; Stranger-Jones et al., 2006; Bubeck Wardenburg & Schneewind, 2008; Lin et al., 2009; Kim et al., 2010).”
BackgroundMethod
Cited by
Bahar, A., & Ren, D. (2013) · Pharmaceuticals · doi:10.3390/ph6121543 · Cited by 1,351
Staphylococcus aureus biofilms: Properties, regulation, and roles in human disease
Archer, N. K., Mazaitis, M. J., Costerton, J. W., Leid, J. G., Powers, M. E., & Shirtliff, M. E. (2011) · Virulence · doi:10.4161/viru.2.5.17724 · Cited by 1,018
Self-citationMolecular Basis of In Vivo Biofilm Formation by Bacterial Pathogens
Joo, H.-S., & Otto, M. (2012) · Chemistry & Biology · doi:10.1016/j.chembiol.2012.10.022 · Cited by 434
Otto, M. (2018) · Microbiology Spectrum · doi:10.1128/microbiolspec.gpp3-0023-2018 · Cited by 381
Pathogenesis and treatment concepts of orthopaedic biofilm infections
Zimmerli, W., & Moser, C. (2012) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2012.00938.x · Cited by 343
Metadata
- Authors
- Harro, J. M., Peters, B. M., O'May, G. A., Archer, N., Kerns, P., Prabhakara, R., & Shirtliff, M. E.
- Venue
- FEMS Immunology & Medical Microbiology
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-08
- Volume
- 59
- Issue
- 3
- Pages
- 306-323
- ISSN
- 0928-8244 (ISSN-L)
- 1574-695X
- OpenAlex
- W1852799255
- Cited by
- 109
- References
- 8
- FWCI
- 6.53
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Vaccine development in Staphylococcus aureus: taking the biofilm phenotype into consideration. https://app.cochat.ai/papers/10.1111/j.1574-695x.2010.00708.x
- The paper
- Harro, J. M., Peters, B. M., O'May, G. A., Archer, N., Kerns, P., Prabhakara, R., & Shirtliff, M. E. (2010). Vaccine development in Staphylococcus aureus: taking the biofilm phenotype into consideration. FEMS Immunology & Medical Microbiology. https://doi.org/10.1111/j.1574-695x.2010.00708.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.